Five Stocks to Watch

Five Stocks to Watch

Jessica Amir
Market Strategist

Summary:  Watch our three minute video covering five stocks to watch this week. In no particular order stocks to watch include Dexcom which has become the best-performing stock in the S&P500 this month after announcing its newest glucose wearable device is available globally. Marathon Oil is another to watch which has been rallying after OPEC+ production cuts were announced. Plus what to watch when it comes to JPMorganChase’s results. And why to also keep Rivian and Fortescue Metals on your radar

Here are five stocks to perhaps watch in no particular order 



Dexcom (DXCM)

Dexcom is so far the best performing stock in the S&P500 this month up 24% after announcing its newest glucose wearable device, Dexcom G7 is available globally, to those with diabetes aged 2 years and over. The wearable device is now selling in the UK, Ireland, Germany, Austria, and Hong Kong, with launches to take place soon in New Zealand and South Africa. 

Marathon Oil (MRO)

Marathon Oil is also one of the best performers in the S&P500 so far this month, up 20%. Marathon Oil along with many oil and gas producers have been rallying this month following the Oil price (West Texas Intermediate) moving up 16% in 11 days. It comes as OPEC+ agreed to reduce oil output by 2 million barrels a day from November. So the market is once again dealing with supply fears in the oil market. 

 

JPMorganChase (JPM)

JPMorgan is the 14th biggest US stock among the S&500. It’s due to report third-quarter financial quarter results in the second week of October along with Morgan Stanley (MS) and Citigroup (C). The two key things to watch with banks are their net interest margin and if that’s improving or weakening. Secondly, keep an eye on the quality of the banks' loan books - and if they’ve deteriorated or improved. 

 

Rivian (RIVN)

Rivian announced the EV maker is recalling 13,000 vehicles it delivered to customers, that’s nearly all the vehicles it sold. It comes as the company found a minor structural defect. Even though Rivian says the issue was discovered in seven vehicles, it recalled all out of caution 

Fortescue Metals (FMG)

Fortescue Future Industries, teamed up with fellow ASX-listed company Incitec Pivot (IPL) to convert IPL’s ammonia facility into a hydrogen electrolysis hub. A Final Investment Decision is not expected to be made until 2023. However, its hoped the hub will produce green ammonia, which can be exported, used in fertilizer, or used as a low-carbon fuel source for heavy transport, airports, and ports. 


To find out more head to Saxo. 
Type in the Stock you want. And click on the Overview page for fundamental analysis. 



-


For a global look at markets – tune into our Podcast.



 

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged foreign exchange trading); Type 4 Regulated Activity (Advising on securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.